ROCKVILLE, Md.–Axeq Technologies announced the industry-first Axeq Turnkey Discovery analytical bioinformatic services coupled with high-coverage exome sequencing applications. The fully-integrated sequencing and analysis services enable researchers to perform exome sequencing and determine putative genetic variant candidates within a few weeks. The Turnkey Discovery processes are categorized into specific modules, and are applicable to a variety of research designs including samples from trios, sib pairs, extended families, and case-control studies.

The Axeq Turnkey Discovery services provide –

•Data filtering, mapping and removal of poor quality variants

•Sequential filtering of variants, based on clients’ definitions, with extensive annotations

•Comparisons of genetic variants among affected individuals and controls

•Determination of putative candidates

•Sanger sequencing services for further candidate validation at very competitive pricing

Introductory Package

Axeq also announced an introductory package priced at US$9,000. This integrated service package includes: exome sequencing of three samples of a trio family (two parents and one affected child) at 75-fold coverage; application of the complete Axeq Turnkey Discovery bioinformatic analysis to the resultant exome sequence data; and the delivery of a list of putative and robust candidates.

“The comprehensive Turnkey Discovery services present medical researchers, often with limited bioinformatics expertise, the exciting opportunity to complete projects, from patient samples to initial discovery, in a matter of just a few weeks,” said Daniel Siu, Executive Vice President of Axeq. “The $9,000 introductory package makes the services even more affordable to many investigators with small budgets”

About Axeq Technology

Headquartered in Rockville, Maryland, USA, Axeq Technologies is a US-division of Korea-based Macrogen, Inc. Axeq is a global provider of next-generation sequencing, Sanger sequencing and data analysis services. Using its unique positions in genetic research, production-level capacity in DNA and RNA sequencing, global operations and cost management, Axeq offers the best technologies at very competitive pricing to clients. Axeq operates laboratories and offices in the US, Europe, Japan and South Korea. Axeq sequencing processes are ISO 9001 and ISO 13458 certified.

For information about Axeq Technologies and our services, please contact Daniel Siu, executive vice president, at [email protected] or visit our website at www.axeq.com